Although the discovery of the oncogenic activation of the K-Ras protein in a lung tumor cell line was described as early as 1984 [164], all attempts to find an effective targeted therapy for lung cancer patients were unsuccessful [165,166]. Here, KRAS is linked to lung neoplasm.